10.6084/m9.figshare.10078130.v1
Paul Emery
Paul
Emery
Daniel E. Furst
Daniel E.
Furst
Petra Kirchner
Petra
Kirchner
Simone Melega
Simone
Melega
Stuart Lacey
Stuart
Lacey
Patricia B. Lehane
Patricia B.
Lehane
Risk of Malignancies in Patients with Rheumatoid Arthritis Treated with Rituximab: Analyses of Global Postmarketing Safety Data and Long-Term Clinical Trial Data
Adis Journals
2019
Database
Malignancy
Real-world
Rheumatoid arthritis
Rituximab
Safety
2019-11-18 13:26:44
Figure
https://adisjournals.figshare.com/articles/figure/Risk_of_Malignancies_in_Patients_with_Rheumatoid_Arthritis_Treated_with_Rituximab_Analyses_of_Global_Postmarketing_Safety_Data_and_Long-Term_Clinical_Trial_Data/10078130
<p><strong>Provide enhanced digital features for this article</strong><br></p><p>
If you are an author of this publication and would like to provide additional
enhanced digital features for your article then please contact <u>adisrapidplus@springer.com</u>.<br>
<br>
The journal offers a range of additional features designed to increase
visibility and readership. All features will be thoroughly peer reviewed to
ensure the content is of the highest scientific standard and all features are
marked as ‘peer reviewed’ to ensure readers are aware that the content has been
reviewed to the same level as the articles they are being presented alongside.
Moreover, all sponsorship and disclosure information is included to provide
complete transparency and adherence to good publication practices. This ensures
that however the content is reached the reader has a full understanding of its
origin. No fees are charged for hosting additional open access content.<br>
<br>
Other enhanced features include, but are not limited to:<br>
• Slide decks<br>
• Videos and animations<br>
• Audio abstracts<br>
• Audio slides</p>